Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Inflammation, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: patient experienced a 3-4 inch red, raised, itchy, warm area at the injection site; patient experienced a 3-4 inch red, raised, itchy, warm area at the injection site/injection site redness; warm area at the injection site; achy joints; swelling/patient experienced a 3-4 inch red, raised, itchy, warm area at the injection site; her arm has stayed inflamed and it growing a little.; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: 30145BA), via an unspecified route of administration, administered in Arm Left on 29Sep2021 14:00 (at the age of 60-year-old) as dose 3 (booster), single for COVID-19 immunization. The patient had no medical history. The patient had no family medical history relevant to AE(s). There were no concomitant medications. The patient had no additional vaccines administered on same date of the Pfizer Suspect considered as suspect. The patient had no prior vaccinations within four weeks prior to the first administration date of the suspect vaccine(s). The patient had no AE(s) following prior vaccinations. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3246), via an unspecified route of administration, administered in Arm Left on 14Jan2021 (at the age of 59-year-old) for COVID-19 immunization. The patient also received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9263), via an unspecified route of administration, administered in Arm Left on 04Feb2021 (at the age of 59-year-old) for COVID-19 immunization and experienced had a sore arm for a day or two after this dose of the vaccine. The patient received the 3rd dose of the Pfizer COVID 19 Vaccine on 29Sep2021, Wednesday. On 01Oct2021 Friday, the patient experienced a 3-4 inch red, raised, itchy, warm area at the injection site. The swelling has gone down, but not completely gone away, the area itself has spread out. It was about 2.5 inches, not its around 3 inches or so. It had gotten better though, than it was. The area was still itchy and warm. Verifies that the area is at the injection site from her third dose of the vaccine. States that the first two days or so after the vaccine she had achy joints. This occurred on Friday and Saturday. She had recovered completely from this symptom. States that her arm had stayed inflamed and it growing a little. The patient denied any other medications, medical conditions, labs, testing, or treatments relevant to these events. The patient would like to know if this has been reported and "hoping" this is considered normal and she does not need to follow up. The patient was informed that adverse reactions following the Pfizer-BioNTech COVID-19 Vaccine that have been reported in clinical trials include injection site pain, injection site swelling, injection site redness, Adverse Reactions in Post Authorization Experience Other hypersensitivity - reactions (e.g., rash, pruritus, urticaria,) Pfizer-BioNTech COVID-19 Vaccine outside of clinical trials. The patient also enquired the time frame of these side effects as she had been reading some literature on her own. The patient was advised that the trials were done within 7 days after the dose as noted in the tables discussing side effects noted by the patient. AE(s) did not require a visit to Emergency Room or Physician Office. The patient had no relevant tests done. Outcome of the events a 3-4 inch red, raised, itchy, warm area at the injection site was recovering; achy joints was recovered on 02Oct2021; inflammation was not recovered.  No follow-up attempts are needed. No further information is expected.